SMBR.JK
PT Semen Baturaja (Persero) Tbk
JakartaIDREQUITY
Basic Materials
DELAYED
Last price
170.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
170.00
Prev close
170.00
Day high
171.00
Day low
168.00
Volume
1.77M
Market cap
$1.69T
P/E (TTM)
12.13
52W range
129.00 – 322.00
Day trading desk
Gap from prior close
+1.80%
Prior close 167.00
VWAP
169.37
+0.37% from price
Relative volume
1.37×
Normal
Session range
1.79%
168.00 – 171.00
Position in range
67%
Mid range
ATR (14D)
5.64
3.32% of price
Prior day high
168.00
PDH
Prior day low
165.00
PDL
Bid / ask spread
—
Quote not published
Session volume
4.73M
Avg 3.46M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.41%
+3.5%
1M
+2.41%
-1.0%
3M
+3.66%
+1.2%
6M
-37.96%
-49.9%
YTD
-40.97%
-53.0%
1Y
-44.08%
-64.3%
3Y
-51.70%
-126.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SMBR.JK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
8.87B
Total on file
Fundamentals
Market cap$1.69T
Enterprise value$2.14T
Revenue (TTM)$2.27T
Gross profit$648.36B
EBITDA$402.68B
Net income$140.29B
EPS (TTM)$14.01
Free cash flow$208.68B
Total cash$72.61B
Total debt$521.58B
Book value / share$345.33
Shares outstanding9.93B
Float2.43B
Short % of float—
Dividend yield2.04%
Beta (5Y)0.37
Valuation & profitability ratios
Trailing P/E12.13
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.49
EV / revenue0.94
EV / EBITDA5.31
Gross margin28.52%
Operating margin5.61%
Profit margin6.17%
Return on equity4.16%
Return on assets2.78%
Debt / equity15.21
Current ratio1.48
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.36T | $2.09T | $2.04T | $1.88T | +12.9% |
| Operating revenue | $2.36T | $2.09T | $2.04T | $1.88T | +12.9% |
| Cost of revenue | $1.65T | $1.49T | $1.40T | $1.11T | +10.5% |
| Gross profit | $712.84B | $598.45B | $645.02B | $768.92B | +19.1% |
| Research & development | $829.35M | $364.40M | $328.98M | $231.29M | +127.6% |
| Selling, general & admin | $282.74B | $199.94B | $234.14B | $263.79B | +41.4% |
| Total operating expense | $444.25B | $364.66B | $431.29B | $507.27B | +21.8% |
| Operating income | $268.59B | $233.79B | $213.73B | $261.65B | +14.9% |
| Net interest income | -$50.93B | -$74.74B | -$93.51B | -$150.99B | +31.9% |
| Pre-tax income | $234.43B | $171.79B | $162.58B | $102.08B | +36.5% |
| Tax provision | $62.51B | $42.54B | $41.01B | $24.76B | +46.9% |
| Net income | $171.92B | $129.25B | $121.57B | $77.32B | +33.0% |
| Net income to common | $171.92B | $129.25B | $121.57B | $77.32B | +33.0% |
| Basic EPS | 17.00 | 13.00 | 12.00 | 8.00 | +30.8% |
| Diluted EPS | 17.00 | 13.00 | 12.00 | 8.00 | +30.8% |
| EBIT | $287.36B | $250.65B | $261.19B | $264.73B | +14.6% |
| EBITDA | $305.65B | $269.32B | $296.33B | $304.54B | +13.5% |
| Basic shares | 9.93B | 9.93B | 9.93B | 9.93B | 0.0% |
| Diluted shares | 9.93B | 9.93B | 9.93B | 9.93B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $60.85B | $29.84B | $98.39B | $522.92B | +103.9% |
| Cash & short-term investments | $60.85B | $29.84B | $98.39B | $522.92B | +103.9% |
| Accounts receivable | $701.38B | $702.48B | $458.97B | $204.54B | -0.2% |
| Inventory | $232.64B | $236.27B | $245.90B | $226.32B | -1.5% |
| Total current assets | $1.02T | $1.00T | $816.85B | $990.30B | +2.1% |
| Property, plant & equipment | $3.67T | $3.83T | $3.96T | $4.08T | -4.2% |
| Goodwill & intangibles | $9.17B | $9.18B | $12.19B | $20.19B | -0.2% |
| Total assets | $4.77T | $4.91T | $4.86T | $5.24T | -2.8% |
| Total current liabilities | $746.03B | $822.08B | $731.49B | $588.14B | -9.3% |
| Current debt | $220.00B | $210.00B | $175.00B | $99.67B | +4.8% |
| Long-term debt | $185.79B | $395.89B | $597.37B | $1.26T | -53.1% |
| Total debt | $522.19B | $729.06B | $891.76B | $1.48T | -28.4% |
| Total liabilities | $1.36T | $1.64T | $1.69T | $2.17T | -17.0% |
| Retained earnings | $171.92B | $129.25B | $109.90B | -$199.07B | +33.0% |
| Shareholder equity | $3.41T | $3.27T | $3.16T | $3.08T | +4.4% |
| Working capital | $275.32B | $178.60B | $85.35B | $402.16B | +54.2% |
| Net tangible assets | $3.40T | $3.26T | $3.15T | $3.05T | +4.4% |
| Shares issued | 9.93B | 9.93B | 9.93B | 9.93B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$47.76B | -$37.37B | -$102.98B | -$52.79B | -27.8% |
| Investing cash flow | -$50.12B | -$51.95B | -$102.98B | -$52.65B | +3.5% |
| Dividends paid | -$25.85B | -$24.31B | -$18.97B | — | -6.3% |
| Financing cash flow | -$243.38B | -$200.02B | -$617.98B | -$310.10B | -21.7% |
| Free cash flow | $277.65B | $145.17B | $193.52B | $348.13B | +91.3% |
| End cash position | $60.85B | $29.84B | $98.39B | $522.92B | +103.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $439.40B | $579.60B | $566.24B | $527.81B | $683.26B | -24.2% |
| Operating revenue | $439.40B | $579.60B | $566.24B | $527.81B | $683.26B | -24.2% |
| Cost of revenue | $317.30B | $405.92B | $408.48B | $351.82B | $453.52B | -21.8% |
| Gross profit | $122.09B | $173.68B | $157.75B | $176.00B | $229.74B | -29.7% |
| Research & development | $21.67M | $484.62M | $123.55M | $134.03M | — | -95.5% |
| Selling, general & admin | $59.71B | $86.14B | $61.99B | $60.56B | $75.56B | -30.7% |
| Total operating expense | $97.44B | $124.58B | $103.63B | $97.59B | $96.43B | -21.8% |
| Operating income | $24.66B | $49.11B | $54.12B | $78.41B | $133.32B | -49.8% |
| Net interest income | -$8.23B | -$8.75B | -$14.25B | -$15.04B | -$17.68B | +5.9% |
| Pre-tax income | $24.22B | $43.67B | $40.68B | $63.48B | $123.16B | -44.5% |
| Tax provision | $6.89B | $18.06B | $10.02B | $14.51B | $29.52B | -61.8% |
| Net income | $17.32B | $25.62B | $30.66B | $48.96B | $93.64B | -32.4% |
| Net income to common | $17.32B | $25.62B | $30.66B | $48.96B | $93.64B | -32.4% |
| Basic EPS | 2.00 | — | — | 5.00 | — | — |
| Diluted EPS | 2.00 | — | — | 5.00 | — | — |
| EBIT | $33.67B | $53.16B | $55.29B | $78.92B | $141.28B | -36.7% |
| EBITDA | $38.07B | $57.79B | $60.01B | $83.36B | $142.51B | -34.1% |
| Basic shares | 9.93B | — | — | 9.93B | — | — |
| Diluted shares | 9.93B | — | — | 9.93B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $72.61B | $60.85B | $13.17B | $32.38B | $29.84B | +19.3% |
| Cash & short-term investments | $72.61B | $60.85B | $13.17B | $32.38B | $29.84B | +19.3% |
| Accounts receivable | $643.48B | $701.38B | $675.38B | $700.52B | $702.48B | -8.3% |
| Inventory | $259.71B | $232.64B | $273.41B | $272.19B | $236.27B | +11.6% |
| Total current assets | $1.01T | $1.02T | $993.79B | $1.05T | $1.00T | -1.6% |
| Property, plant & equipment | $3.64T | $3.67T | $3.77T | $3.80T | $3.83T | -0.8% |
| Goodwill & intangibles | $8.27B | $9.17B | $7.72B | $8.46B | $9.18B | -9.8% |
| Total assets | $4.73T | $4.77T | $4.84T | $4.92T | $4.91T | -1.0% |
| Total current liabilities | $677.37B | $746.03B | $809.21B | $792.02B | $822.08B | -9.2% |
| Current debt | $220.00B | $220.00B | $220.00B | $210.00B | $210.00B | 0.0% |
| Long-term debt | $187.97B | $185.79B | $291.63B | $398.73B | $395.89B | +1.2% |
| Total debt | $521.58B | $522.19B | $629.64B | $728.18B | $729.06B | -0.1% |
| Total liabilities | $1.30T | $1.36T | $1.52T | $1.61T | $1.64T | -4.7% |
| Retained earnings | $189.25B | $171.92B | $79.62B | $178.22B | $129.25B | +10.1% |
| Shareholder equity | $3.43T | $3.41T | $3.32T | $3.32T | $3.27T | +0.5% |
| Working capital | $328.13B | $275.32B | $184.59B | $260.01B | $178.60B | +19.2% |
| Net tangible assets | $3.42T | $3.40T | $3.31T | $3.31T | $3.26T | +0.5% |
| Shares issued | 9.93B | 9.93B | 9.93B | 9.93B | 9.93B | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$11.07B | -$9.30B | -$14.64B | -$503.19M | -$7.27B | -19.0% |
| Investing cash flow | -$11.07B | -$10.65B | -$15.29B | -$503.19M | -$21.85B | -4.0% |
| Dividends paid | — | $0 | — | — | $7.00K | — |
| Financing cash flow | -$6.86B | -$1.75B | -$131.21B | -$8.81B | $11.70B | -292.2% |
| Free cash flow | $18.05B | $33.36B | $112.50B | $11.09B | $2.23B | -45.9% |
| End cash position | $72.61B | $60.85B | $13.17B | $32.38B | $29.84B | +19.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders89.31%
Held by institutions1.25%
Institutions holding4
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
167.40
+1.55% from price
SMA 20
165.15
+2.94% from price
SMA 50
158.38
+7.34% from price
SMA 100
178.00
-4.49% from price
SMA 200
227.85
-25.39% from price
EMA 12
166.72
+1.97% from price
EMA 26
164.32
+3.46% from price
EMA 50
165.94
+2.44% from price
RSI (14)
59.7
Neutral
MACD (12,26,9)
2.40
Hist 0.00
ATR (14)
5.64
3.32% of price
Realised vol 30D
28.8%
Annualised
Bollinger upper
172.56
20, 2σ
Bollinger lower
157.74
20, 2σ
50 / 200 cross
Death
158.38 vs 227.85
Trend bias
Below 200
-25.39%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.03
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
28.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-58.2%
Peak to trough
Max drawdown 5Y
-84.3%
Peak to trough
ATR 14
5.64
3.32% of price
Beta (reported)
0.37
5Y monthly, from filing
Dividends & splits
Forward rate$3.46 / yr
Forward yield2.04%
5-year avg yield1.18%
Payout ratio18.59%
Ex-dividend dateMay 29, 2026
Next pay date—
Last split—
Split date—
Headlines
Dollar higher after Iran sanctions, loonie drops after US announces tariff increases
Reuters · 1m ago
FS Bancorp Authorizes $5 Million Share Repurchase Program
MT Newswires · 4m ago
Nvidia Makes Aggressive Move Ahead of Earnings
GuruFocus.com · 4m ago
Xiaomi Takes Another Page From Apple
GuruFocus.com · 5m ago
United Bankshares Plans New Share Buyback Program; Maintains Dividend
MT Newswires · 6m ago
IonQ Makes Unexpected Move Beyond Quantum
GuruFocus.com · 6m ago
Home equity loan calculator
Personal Finance Embeddable Content · 7m ago
Outer Biosciences is using human skin that would otherwise be discarded after surgery for AI testing to create customized skincare.
Yahoo Finance · 7m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.